JadiCell™ Adult Donor Multi-Potent Mesenchymal Stell Cell Licensing Detail

JadiCell™ Adult Donor Multi-Potent Mesenchymal Stell Cell uses may be licensed by selecting a disease from brain or lung that isn’t currently licensed by contacting us at licensing@tsoimail.com. The terms are as follows:

This is licensing only and does not include any costs for regulatory and clinical trial work. Initial license fee is $50,000 upfront plus a $10,000 minimum annual royalty for a total of $60,000. Phase 1 is an additional $100,000, Phase 2 is $250,000, Phase 3 $500,000, and BLA is $1,000,000. Each year an annual royalty payment of $10,000 will be due on the anniversay date of initial licensing. And finally there is a 6% royalty due on gross revenues from any succesful applications for use in the general population. This royalty will continue through the life of the patent(s) covering any particular disease.

To enter into clinical trials you may be required to conduct preclinical experiments before you author and file Investigational New Drug Applications (IND). We are available for consulting and asssitance in authoring IND’s. The CMC (chemistry, manufacturing, and control) remains the same regardless of application and the licensing will include the CMC required for an IND.

Trial doses from our own cGMP Master Cell Bank may be obtained from our subsidiary Allogen Biologics, Inc. which may save you costs during clinical phases of investigational research.